OTC Pharmaceuticals - ASEAN | Statista Market Forecast

Revenue in the OTC Pharmaceuticals market amounts to US$9.25bn in 2024. The market is expected to grow annually by 6.98% (CAGR 2024-2029).
The market's largest segment is the segment Vitamins & Minerals with a market volume of US$2.30bn in 2024.
In global comparison, most revenue is generated United States (US$41bn in 2024).
In relation to total population figures, per person revenues of US$13.39 are generated in 2024.
In the OTC Pharmaceuticals market, 16.4% of total revenue will be generated through online sales by 2024.

Definition:
The Over-the-Counter Pharmaceuticals market includes non-prescription medications, treatments, and healthcare products that are available directly to consumers without a prescription from a licensed healthcare professional. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere such as supermarkets, and online retailers. Sales by hospitals are not included.

Structure:
The market is subdivided into Analgesics, Cold and Cough Remedies, Digestives and Intestinal Remedies, Skin Treatment, Vitamins and Minerals, Hand Sanitizer, Eye care, Sleep aids, Wound care, and Other OTC Pharmaceuticals. The Analgesics market covers non-prescription pain-relief medications which help to relief aches, pains and fevers. Cold & Cough market covers non-prescription remedies aimed at relieving nasal congestion, coughing, sore throat, and related cold discomforts. The Digestives and Intestinal Remedies market encompasses non-prescription products designed to alleviate symptoms related to digestive discomfort and intestinal issues. The Skin Treatment market includes non-prescription medications formulated to address various dermatological concerns such as acne, eczema and dryness. The Vitamins and Minerals market comprises non-prescription dietary supplements containing essential nutrients such as vitamins and minerals. The Hand sanitizer market covers sanitizing products which are applied on hands to effectively reduce the presence of bacteria and viruses. The Eye Care market covers non-prescription products to address common eye-related discomforts such as dryness, irritation or redness. The Sleep Aids market covers non-prescription products designed to promote relaxation, alleviate insomnia, and improve sleep quality. The Wound Care market includes non-prescription products designed to facilitate wound healing and prevent infection.

Additional information:
OTC Pharmaceuticals comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Natural and synthetic agents
Analgesics (e.g. Asprin, Paracetamol)
Cough & Cold remedies (e.g. Vicks VapoRub)
Vitamins and Minerals
Skin treatment products

Prescription medicines
Homeopathic remedies

The OTC Pharmaceuticals market in ASEAN is experiencing significant growth and development due to various factors.

Customer preferences: Customers in ASEAN countries have shown a growing preference for over-the-counter (OTC) pharmaceutical products. This can be attributed to several reasons. Firstly, the convenience and accessibility of OTC products without the need for a prescription have made them popular among consumers. Additionally, the increasing awareness and emphasis on self-care and preventive healthcare have led to a higher demand for OTC medications. Customers in ASEAN countries are also becoming more knowledgeable about healthcare and are actively seeking out OTC products to address their specific needs.

Trends in the market: One of the key trends in the OTC Pharmaceuticals market in ASEAN is the rising demand for vitamins and dietary supplements. With the growing focus on health and wellness, consumers are increasingly turning to these products to supplement their diets and maintain overall well-being. This trend is particularly evident in countries like Thailand and Indonesia, where there is a strong cultural emphasis on traditional medicine and natural remedies. Another trend in the market is the increasing popularity of OTC pain relievers and fever reducers. These products are in high demand due to their effectiveness in providing relief from common ailments such as headaches, muscle aches, and fever. With the fast-paced lifestyles and high levels of stress in ASEAN countries, consumers are seeking quick and accessible solutions for their health concerns.

Local special circumstances: Each ASEAN country has its own unique set of circumstances that influence the OTC Pharmaceuticals market. For example, in Singapore, the government's efforts to promote self-medication and reduce healthcare costs have contributed to the growth of the OTC market. In Malaysia, the large population and rising disposable income levels have created a favorable environment for the OTC Pharmaceuticals market to thrive. In Vietnam, the increasing urbanization and changing lifestyle patterns have led to a greater demand for OTC products.

Underlying macroeconomic factors: Several macroeconomic factors are driving the growth of the OTC Pharmaceuticals market in ASEAN. Firstly, the region's strong economic growth and rising middle-class population have increased purchasing power and affordability of healthcare products. Additionally, the growing healthcare infrastructure and improved access to healthcare services have contributed to the demand for OTC medications. The increasing prevalence of chronic diseases and the aging population in some ASEAN countries have also boosted the market as consumers seek OTC products for managing their health conditions. In conclusion, the OTC Pharmaceuticals market in ASEAN is witnessing significant growth and development driven by customer preferences, market trends, local special circumstances, and underlying macroeconomic factors. The increasing demand for OTC products, particularly vitamins and dietary supplements, as well as pain relievers and fever reducers, reflects the changing healthcare landscape in ASEAN countries. With the region's economic growth and improving healthcare infrastructure, the OTC Pharmaceuticals market is expected to continue its upward trajectory in the coming years.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

This report presents a comprehensive analysis and additional information on the Consumer market, in a PDF format.

The global pharmaceutical industry has experienced significant growth during the past two decades, with revenues totaling around 1.6 trillion U.S. dollars in 2023. With growth like that, the industry's size is now comparable to the gross domestic products (GDPs) of countries like Spain, Mexico, or Australia.